Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B

被引：3
|
作者：
Rossetti, B. [1 ]
Bianco, C. [1 ]
De Luca, A. [1 ]
机构：
[1] Univ Siena, Policlin Le Scotte, Div Infect Dis 2, I-53100 Siena, Italy
来源：
INFECTION | 2012年 / 40卷 / 03期
关键词：
ACTIVE ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; COINFECTION; PATIENT; HBV;
D O I：
10.1007/s15010-011-0198-1
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：347 / 349
页数：3
相关论文
共 50 条
  • [41] Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha
    Desai, HG
    NATIONAL MEDICAL JOURNAL OF INDIA, 2003, 16 (03): : 175 - 175
  • [42] Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
    Soriano, Vincent
    Mocroft, Amanda
    Peters, Lars
    Rockstroh, Juergen
    Antunes, Francisco
    Kirkby, Nikolai
    de Wit, Stephane
    Monforte, Antonella d'Arminio
    Flisiak, Robert
    Lundgren, Jens
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (03) : 548 - 555
  • [43] Predictors of loss of hepatitis B surface antigen in HIV-infected patients
    Psevdos, George, Jr.
    Kim, Jong Hun
    Suh, Jin S.
    Sharp, Victoria Lee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (09) : 1093 - 1096
  • [44] A Potent Hepatitis B Surface Antigen Response in Subjects With Inactive Hepatitis B Surface Antigen Carrier Treated With Pegylated-Interferon Alpha
    Cao, Zhenhuan
    Liu, Yali
    Ma, Lina
    Lu, Junfeng
    Jin, Yi
    Ren, Shan
    He, Zhimin
    Shen, Chengli
    Chen, Xinyue
    HEPATOLOGY, 2017, 66 (04) : 1058 - 1066
  • [45] Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B
    Itokawa, Norio
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Toyoda, Hidenori
    Takaguchi, Koichi
    Hiraoka, Atsushi
    Senoh, Tomonori
    Koeda, Mai
    Yoshida, Yuji
    Okubo, Tomomi
    Arai, Taeang
    Hayama, Korenobu
    Nakagawa-Iwashita, Ai
    Kondo, Chisa
    Iwakiri, Katsuhiko
    INTERNAL MEDICINE, 2021, 60 (04) : 507 - 516
  • [46] Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs
    Janssen, HLA
    Lau, GKK
    HEPATOLOGY, 2005, 42 (06) : 1459 - 1459
  • [47] Hepatitis B surface antigen seroconversion in HBeAg negative chronic hepatitis B patient during entecavir treatment
    Altun, Reskan
    Sahinturk, Huseyin
    Sisman, Gurhan
    Baran, Bulent
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 : 272 - 273
  • [48] Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment
    Henry Lik-Yuen Chan
    May-Ling Wong
    Alex Yui Hui
    Angel Mei-Ling Chim
    Ada Mei-Ling Tse
    Lawrence Cheung-Tsui Hung
    Francis Ka-Leung Chan
    Joseph Jao-Yiu Sung
    World Journal of Gastroenterology, 2003, 9 (12) : 2695 - 2697
  • [49] Results of Treatment of Chronic Hepatitis B with Pegylated Interferon
    Vigano, Mauro
    Mangia, Giampaolo
    Lampertico, Pietro
    CLINICS IN LIVER DISEASE, 2013, 17 (03) : 425 - +
  • [50] Hepatitis B e Antigen Seroconversion: A Critical Event in Chronic Hepatitis B Virus Infection
    Liaw, Yun-Fan
    Lau, George K. K.
    Kao, Jia-Horng
    Gane, Edward
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (10) : 2727 - 2734
12345